Inventor · disambiguated record
Joseph Stock
Also filed as: STOCK JOSEPH · STOCK JOSEPH R · STOCK JOSEPH RAYMOND
14 granted patents·8 pending applications·199 citations·filing 2001–2021
92Inventor score
Top patents by PatentIndex Score
22 records- 0193US6610734B2Heterocyclic sulfonamide inhibitors of beta amyloid productionWYETH CORP·Filed 2001·Granted Aug 26, 2003·53 cites·94 claims
- 0292US6878742B2Heterocyclic sulfonamide inhibitors of beta amyloid productionWYETH CORP·Filed 2003·Granted Apr 12, 2005·40 cites·7 claims
- 0390US7488832B2Azolylacylguanidines as β-secretase inhibitorsWYETH CORP·Filed 2006·Granted Feb 10, 2009·19 cites·8 claims
- 0488US7166622B2Substituted phenylsulfonamide inhibitors of beta amyloid productionARQULE INC·Filed 2003·Granted Jan 23, 2007·26 cites·17 claims
- 0586US6800764B2Process for the synthesis of chirally pure beta-amino-alcoholsWYETH CORP·Filed 2002·Granted Oct 5, 2004·17 cites·47 claims
- 0686US6770642B2Indolylalkylamine derivatives as 5-hydroxytryptamine-6 ligandsWYETH CORP·Filed 2002·Granted Aug 3, 2004·23 cites·19 claims
- 0784US11203611B2Immunomodulating polynucleotides, antibody conjugates thereof, and methods of their useSOLSTICE BIOLOGICS LTD·Filed 2018·Granted Dec 21, 2021·5 cites·35 claims
- 0880US7691884B2Heterocyclic sulfonamide inhibitors of β amyloid productionWYETH CORP·Filed 2005·Granted Apr 6, 2010·3 cites·16 claims
- 0978US7022701B2Indolylalkylamine derivatives as 5-hydroxytryptamine-6 ligandsWYETH CORP·Filed 2004·Granted Apr 4, 2006·10 cites·9 claims
- 1076US7842718B2Heterocyclic sulfonamide inhibitors of beta amyloid productionWYETH LLC·Filed 2009·Granted Nov 30, 2010·1 cites·12 claims
- 1173US7671075B2Substituted phenylsulfonamide inhibitors of beta amyloid productionWYETH CORP·Filed 2006·Granted Mar 2, 2010·1 cites·12 claims
- 1271US7820825B2N-substituted-azacyclylamines as histamine-3 antagonistsWYETH LLC·Filed 2007·Granted Oct 26, 2010·1 cites·11 claims
- 1366US12351598B2Immunomodulating polynucleotides, antibody conjugates thereof, and methods of their useTALLAC THERAPEUTICS INC·Filed 2021·Granted Jul 8, 2025·0 cites·44 claims
- 1456US2008287424A1AZOLYLACYLGUANIDINES AS beta-SECRETASE INHIBITORSWYETH CORP·Filed 2008·Application pending·0 cites
- 1555US2009325964A1Piperazine Metabotropic Glutamate Receptor 5 (MGLUR5) Negative Allosteric Modulators For Anxiety/DepressionWYETH CORP·Filed 2009·Application pending·0 cites
- 1655US2011034513A1Heterocyclic Sulfonamide Inhibitors of Beta Amyloid ProductionWYETH LLC·Filed 2010·Application pending·0 cites
- 1753US2020392498A1Polynucleotide constructs having bioreversible and non-bioreversible groupsSOLSTICE BIOLOGICS LTD·Filed 2020·Application pending·0 cites
- 1848US2010120725A1Substituted Phenylsulfonamide Inhibitors of Beta Amyloid ProductionWYETH LLC·Filed 2010·Application pending·0 cites
- 1944US2007027199A1Cycloalkyl amino-hydantoin compounds and use thereof for beta-secretase modulationWYETH CORP·Filed 2006·Application pending·0 cites
- 2043US7842715B2N-benzoyl- and N-benzylpyrrolidin-3-ylamines as histamine-3 antagonistsWYETH LLC·Filed 2007·Granted Nov 30, 2010·0 cites·14 claims
- 2143US2017114341A1Polynucleotide constructs having bioreversible and non-bioreversible groupsBRADSHAW CURT W·Filed 2015·Application pending·0 cites
- 2239US2019194655A1Polynucleotide constructs having an auxiliary moiety non-bioreversibly linked to an internucleoside phosphate or phosphorothioateBRADSHAW CURT W·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Joseph Stock files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →